Delivering future health solutions.
Health & Life Sciences
Major European Biomanufacturing cluster
Highest number of specialist hospitals outside of London
Home to the world renowned Liverpool School of Tropical Medicine
The highest concentration of Category Level 3 laboratories in the UK
There is no better validation of Liverpool City Region’s medical credentials than the global players that choose to locate and reinvest here. From stem cell and gene therapy treatments and nutraceuticals research and development, to large scale manufacturing and the production of pharmaceuticals, vaccines and biologics.
Liverpool City region is home to companies delivering world-class solutions in life sciences from research and trials to medical manufacturing, including AstraZeneca; Allergan; Baxter Healthcare, Bristol Myers Squibb; Lilly; Nestlé Health Science; Seqirus and Unilever. Significant new investments in modern production facilities at these companies have created a vibrant, efficient and cost-competitive environment to produce new drugs and vaccines.
The emergence of sensor technologies, big data and robotics is changing the possibilities and processes in the life sciences sector. Liverpool City Region is leading the way with its LCR 4.0 programme, creating a new infrastructure that connects physical and digital assets to make the industrial internet a reality. The Hartree Centre at Sci-Tech Daresbury is shaping the future of digital UK pharmaceutical design, development and manufacturing through big data analytics expertise.
Get in touch
- +44(0)151 237 3918
Latest Health & Life Sciences news
COVID testing firm invests £2m in second Liverpool City Region site
Liverpool City Region’s BioGrad Diagnostics is investing more than £2m in a new site ias demand for COVID-19 testing rockets. Based at Liverpool Science Park, BioGrad is to open a new base at St Hugh’s House in Stanley Road in Bootle. Opening on June 20, it will include a clinic, customer service call centre and […]
Liverpool Science Park Unveils Stunning New Entrance
Sciontec Developments Limited, has revealed its brand-new entrance at Liverpool Science Park (LSP).
Liverpool City Region’s Seqiris Strengthens UK influenza vaccine response following £50 million investment
Seqirus has strengthened the UK’s vaccine response to influenza as its high-speed syringe filling and packing facility in Liverpool starts rolling out millions of doses.
MAYORS UNITE TO OPEN ONE OF WORLD’S HEALTHIEST BUILDINGS
Liverpool’s new Mayor and the City Region’s Metro Mayor will officially open one of the world’s healthiest buildings today (Friday, 21 May).
Life Science & Biomedical Virtual Business Pitching Event with BioNow
Wednesday 30th June, 10.00 – 11.30 am. Bionow and Sci-Tech Daresbury will be co-hosting a virtual business pitching event for companies operating in the life science and biomedical sector.
Bionow Pharma Manufacturing Conference
The Bionow Pharma Manufacturing Conference will explore the challenges and opportunities for pharma manufacturing in the North.
£3M INVESTMENT DOUBLES WAREHOUSE CAPACITY AND CREATES 25 JOBS
Preventative healthcare company PAM Group has doubled the warehouse capacity for its specialist retail business with a £3m investment in new premises in Liverpool City Region.